Chemical Neuromodulation: Neurobiological, Neurocomputational, Behavioural and Clinical Aspects
18-24 June 2017 - Bertinoro, Italy
Chemical neuromodulation refers to that set of neurotransmitter systems that arise in the subcortical brain to influence the functions of forebrain networks to produce behaviour and cognitive outputs, under a variety of different states of arousal. These neurotransmitter systems, which include the monoamines such as dopamine, noradrenaline and serotonin, as well as acetylcholine and orexin, are implicated in diverse behavioural and physiological functions and have been implicated in many neuropsychiatric and neurological disorders. The systems have been extensively researched in isolation but have rarely been directly compared experimentally or in conceptual terms; hence one theme of this School will be to make such comparisons.
The basic neuroscience of these neurotransmitter systems will be covered by lectures and discussion groups by an international faculty. Organization and functions of the systems will be compared using a range of multidisciplinary techniques and approaches. These will include the use of novel neuroscience tools provided by opto- and chemo-genetics, electrophysiology, neuropharmacological techniques such as in vivo voltammetry, combined with sophisticated theoretical approaches from cognitive and behavioural neuroscience, including neurocomputational approaches and neuroimaging in experimental animals and humans. Clinical applications will also be covered. Students will be required to present posters on related themes in special sessions with the visiting faculty and active group discussions will be encouraged.
Dr. Gary Aston-Jones, Rutgers Brain Health Institute, USA
Dr. Roshan Cools, Donders Institute for Brain, Cognition and Behaviour, The Netherlands
Dr. Emrah Düzel, German Center for Neurodegenerative Diseases (DZNE), Germany
Dr. Anthony Grace, University of Pittsburgh, USA
Dr. Michael Hasselmo, Boston University, USA
Dr. Gitte Moos Knudsen, Copenhagen University Hospital, Denmark
Dr. Zachary Mainen, Champalimaud Neuroscience Programme, Portugal
Dr. James Rowe, University of Cambridge, UK
Dr. Mark Walton, University of Oxford, UK
Registration and stipends
- Fee: FENS Members: 495 EUR
FENS Non-members: 575 EUR
- Registration fee covers tuition, accommodation and meals.
- FENS offers a number of stipends (covering the registration fee) available for candidates from disadvantaged countries. Any applicant in need of a grant should however first try to request it from the lab, institution or government if possible.Once an applicant has been accepted to the school, the available grants will be provided on the basis of need.
- Applications are closed.
A feel of the Summer School
Bertinoro, Training Center of the University of Bologna, Italy
For enquiries, please contact: email@example.com